Noxafil Powdermix — Class II drug recall D-0242-2026
Ongoing recall by Merck Sharp & Dohme LLC, reported 2025-12-31, distributed nationwide. Presence of particulate matter: potential presence of metal particulates in the product.
| Recall number | D-0242-2026 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | Merck Sharp & Dohme LLC, Wilson, NC, United States |
| Recall initiated | 2025-12-12 |
| Classified | 2025-12-23 |
| Reported by FDA | 2025-12-31 |
| Distributed | Nationwide (US) |
| Quantity | 845 kits |
| Reason classes | specification failure |
| NDC | 00085-1328, 00085-1328-01, 00085-2224, 00085-2224-01, 00085-2224-02, 00085-4324, 00085-4324-02, 00085-4331, 00085-4331-01 |
| Lot numbers | Z009908, Z009909, Z010344, Z012339 |
| Expiration dates | 2026-12-31 |
Product
Noxafil Powdermix (posaconazole) for Delayed-Release Oral Suspension, 300 mg, 8 packets per carton, Rx Only, Manufactured for: Merck Sharp & Doohme LLC, Rahway, NJ 07056 USA, Manufactured by: N.V. Organon, 5349 AB Oss, The Netherlands, a subsidiary of Organon & Co., Jersey City, NJ 07302, USA NDC 0085-2224-02.
Reason for recall
Presence of particulate matter: potential presence of metal particulates in the product.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0242-2026. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.